Delhi: With the Budget around the corner, market veteran Madhusudan Kela expressed confidence that fiscal discipline will continue, while highlighting opportunities emerging from market corrections. “…During the course of the year, a lot could come. There is a clear revenue gap due to tax cuts, but there has been enough expenditure saving and plus the […]
Abbott Laboratories (NYSE:ABT) is included among the 12 Most Profitable Dividend Stocks to Buy in 2026. Evercore ISI Says Abbott’s (ABT) Core Growth Drivers Are Still Intact Courtesy of Abbott Labs On January 23, Evercore ISI trimmed its price target on Abbott Laboratories (NYSE:ABT) to $138 from $144. However, it kept an Outperform rating. The […]